Management of high-grade papillary Ta or T1 bladder cancer after restaging transurethral resection: A retrospective study comparing Bacillus Calmette-Guerin therapy upfront versus a third resection

CONCLUSIONS: The efficacy of intravesical BCG is compromised in case of residual tumour following TURB. The role of a 3TURB following a positive reTURB is not yet determined. This study has confirmed that residual tumor following reTURB is a negative predictive factor but could not demonstrate the value of a 3TURB compared to upfront BCG.PMID:37980231 | DOI:10.1016/j.purol.2023.10.002

Source: Progres en Urologie - November 18, 2023 Category: Urology & Nephrology Authors: Q Arnaud P Sebe A Colau M Mouton F Desgrandchamps A Masson-Lecomte T Bessede J Irani I Dominique Source Type: research